Literature DB >> 24597649

Critical role of the endogenous interferon ligand-receptors in type I and type II interferons response.

Ahmed Lasfar1, Jeffry R Cook, Karine A Cohen Solal, Kenneth Reuhl, Sergei V Kotenko, Jerome A Langer, Debra L Laskin.   

Abstract

Separate ligand-receptor paradigms are commonly used for each type of interferon (IFN). However, accumulating evidence suggests that type I and type II IFNs may not be restricted to independent pathways. Using different cell types deficient in IFNAR1, IFNAR2, IFNGR1, IFNGR2 and IFN-γ, we evaluated the contribution of each element of the IFN system to the activity of type I and type II IFNs. We show that deficiency in IFNAR1 or IFNAR2 is associated with impairment of type II IFN activity. This impairment, presumably resulting from the disruption of the ligand-receptor complex, is obtained in all cell types tested. However, deficiency of IFNGR1, IFNGR2 or IFN-γ was associated with an impairment of type I IFN activity in spleen cells only, correlating with the constitutive expression of type II IFN (IFN-γ) observed on those cells. Therefore, in vitro the constitutive expression of both the receptors and the ligands of type I or type II IFN is critical for the enhancement of the IFN activity. Any IFN deficiency can totally or partially impair IFN activity, suggesting the importance of type I and type II IFN interactions. Taken together, our results suggest that type I and type II IFNs may regulate biological activities through distinct as well as common IFN receptor complexes.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  T cells; cell types; constitutive interferon; interferon receptor paradigm; interferon response; type I and type II interferon receptors

Mesh:

Substances:

Year:  2014        PMID: 24597649      PMCID: PMC4080960          DOI: 10.1111/imm.12273

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  60 in total

Review 1.  alpha-Interferon in hematological malignancies.

Authors:  F J Giles; H Ozer
Journal:  Curr Opin Biotechnol       Date:  1991-12       Impact factor: 9.740

2.  IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex.

Authors:  Sergei V Kotenko; Grant Gallagher; Vitaliy V Baurin; Anita Lewis-Antes; Meiling Shen; Nital K Shah; Jerome A Langer; Faruk Sheikh; Harold Dickensheets; Raymond P Donnelly
Journal:  Nat Immunol       Date:  2002-12-16       Impact factor: 25.606

3.  Convenient assay for interferons.

Authors:  S Rubinstein; P C Familletti; S Pestka
Journal:  J Virol       Date:  1981-02       Impact factor: 5.103

Review 4.  Cytokine therapeutics: lessons from interferon alpha.

Authors:  J U Gutterman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

5.  Identification and sequence of an accessory factor required for activation of the human interferon gamma receptor.

Authors:  J Soh; R J Donnelly; S Kotenko; T M Mariano; J R Cook; N Wang; S Emanuel; B Schwartz; T Miki; S Pestka
Journal:  Cell       Date:  1994-03-11       Impact factor: 41.582

6.  Identification of a yeast artificial chromosome clone encoding an accessory factor for the human interferon gamma receptor: evidence for multiple accessory factors.

Authors:  J Soh; R J Donnelly; T M Mariano; J R Cook; B Schwartz; S Pestka
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

7.  Modulation of interferon-gamma receptor during human T lymphocyte alloactivation.

Authors:  F Novelli; M Giovarelli; R Gentz; M Zucca; F di Pierro; G Garotta; G Forni
Journal:  Eur J Immunol       Date:  1993-06       Impact factor: 5.532

8.  Functional role of type I and type II interferons in antiviral defense.

Authors:  U Müller; U Steinhoff; L F Reis; S Hemmi; J Pavlovic; R M Zinkernagel; M Aguet
Journal:  Science       Date:  1994-06-24       Impact factor: 47.728

9.  Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-alpha and -gamma signal transduction pathways.

Authors:  M Müller; C Laxton; J Briscoe; C Schindler; T Improta; J E Darnell; G R Stark; I M Kerr
Journal:  EMBO J       Date:  1993-11       Impact factor: 11.598

10.  CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major.

Authors:  Z E Wang; S L Reiner; S Zheng; D K Dalton; R M Locksley
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

View more
  10 in total

1.  HIPK2 is necessary for type I interferon-mediated antiviral immunity.

Authors:  Lili Cao; Guang Yang; Shandian Gao; Chunxia Jing; Ruth R Montgomery; Yuxin Yin; Penghua Wang; Erol Fikrig; Fuping You
Journal:  Sci Signal       Date:  2019-03-19       Impact factor: 8.192

2.  Comprehensive network map of interferon gamma signaling.

Authors:  Mohd Younis Bhat; Hitendra S Solanki; Jayshree Advani; Aafaque Ahmad Khan; T S Keshava Prasad; Harsha Gowda; Saravanan Thiyagarajan; Aditi Chatterjee
Journal:  J Cell Commun Signal       Date:  2018-09-06       Impact factor: 5.782

Review 3.  IFN-λ cancer immunotherapy: new kid on the block.

Authors:  Ahmed Lasfar; Helen Gogas; Andrew Zloza; Howard L Kaufman; John M Kirkwood
Journal:  Immunotherapy       Date:  2016-07       Impact factor: 4.196

4.  Tacrolimus interacts with voriconazole to reduce the severity of fungal keratitis by suppressing IFN-related inflammatory responses and concomitant FK506 and voriconazole treatment suppresses fungal keratitis.

Authors:  Jing Zhong; Lulu Peng; Bowen Wang; Henan Zhang; Saiqun Li; Ruhui Yang; Yuqing Deng; Haixiang Huang; Jin Yuan
Journal:  Mol Vis       Date:  2018-03-04       Impact factor: 2.367

Review 5.  Interferon-γ acts as a regulator in the trade-off between phagocytosis and production performance in dwarf chickens.

Authors:  Yitong Yuan; Shunqi Liu; Yue Zhao; Ling Lian; Zhengxing Lian
Journal:  J Anim Sci Biotechnol       Date:  2018-05-23

6.  IFNλ is a potent anti-influenza therapeutic without the inflammatory side effects of IFNα treatment.

Authors:  Sophia Davidson; Teresa M McCabe; Stefania Crotta; Hans Henrik Gad; Edith M Hessel; Soren Beinke; Rune Hartmann; Andreas Wack
Journal:  EMBO Mol Med       Date:  2016-09-01       Impact factor: 12.137

7.  Dysregulation of the IFN-γ-STAT1 signaling pathway in a cell line model of large granular lymphocyte leukemia.

Authors:  Paige M Kulling; Kristine C Olson; Cait E Hamele; Mariella F Toro; Su-Fern Tan; David J Feith; Thomas P Loughran
Journal:  PLoS One       Date:  2018-02-23       Impact factor: 3.240

8.  In vivo imaging of Zika virus reveals dynamics of viral invasion in immune-sheltered tissues and vertical propagation during pregnancy.

Authors:  Ting Wang; Penghui Li; Yuan Zhang; Yan Liu; Zhongyuan Tan; Jianhong Sun; Xianliang Ke; Yuanjiu Miao; Dan Luo; Qinxue Hu; Fuqiang Xu; Hanzhong Wang; Zhenhua Zheng
Journal:  Theranostics       Date:  2020-05-16       Impact factor: 11.556

Review 9.  The Many Faces of JAKs and STATs Within the COVID-19 Storm.

Authors:  Alice H Grant; Armando Estrada; Yoshira M Ayala-Marin; America Y Alvidrez-Camacho; Georgialina Rodriguez; Elisa Robles-Escajeda; Denisse A Cadena-Medina; Alejandro C Rodriguez; Robert A Kirken
Journal:  Front Immunol       Date:  2021-07-13       Impact factor: 7.561

10.  Mitochondrial respiration contributes to the interferon gamma response in antigen-presenting cells.

Authors:  Michael C Kiritsy; Katelyn McCann; Daniel Mott; Steven M Holland; Samuel M Behar; Christopher M Sassetti; Andrew J Olive
Journal:  Elife       Date:  2021-11-02       Impact factor: 8.140

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.